Make a selection below






5th International Conference on Viral Hepatitis

Hotel Nikko - San Francisco, CA

September 21-22, 2015



The 5th International Conference on Viral Hepatitis is sponsored by the International Association of Providers of AIDS Care (IAPAC), in partnership with the University of California, San Francisco (UCSF), and the International Association for the Study of the Liver (IASL).

The annual conference a forum for the presentation of state-of-the-art approaches to the clinical management of viral hepatitis, specifically hepatitis B virus (HBV) and hepatitis C virus (HCV) infection, with the aim of supporting a wide variety of clinicians, including non-liver specialists, as they integrate scientific advances into real-world clinical practice settings. 


The target audience for this conference includes liver specialists (gastroenterologists & hepatologists), non-liver specialists (ID-specialized & HIV physicians), nurses, and pharmacists.


The University of California, San Francisco, designates this live activity for a maximum of 10.5 AMA PRA Category 1 Credit(s)™. Continuing education credit applications for nurses and pharmacists are pending.


Space is available to commercial (for profit) and non-profit/government entities wishing to exhibit. The exhibit fee is $3,000 for commercial and $2,000 for non-profit/government entities. An exhibit fee is required for exhibitors. The costs subsidized by these fees are incremental to the exhibit spaces. We further stipulate that exhibit payments are not intended to influence the planning of or influence with presentations delivered at this activity.

To access an Exhibitor Application Form, please contact


Following are key dates relevant to registration, accommodations, and abstract submission:

  • Abstract Submission Deadline – July 31, 2015
  • Early Registration Deadline - August 7, 2015
  • Abstract Disposition Announcements – August 7, 2015
  • Standard Registration Deadline – September 19, 2015
  • Early Registration Rate (for presenting authors only) – August 14, 2015
  • Deadline to Withdraw Abstract /Change Presenting Author – September 4, 2015
  • Discounted Room Block Reservation Deadline – August 20, 2015


The annual series of International Conferences on Viral Hepatitis (ICVH) is focused on expanding the universe of clinicians who can manage hepatitis B virus (HBV) and hepatitis C virus (HCV) monoinfection and coinfection with HIV. The conference aims to improve patient outcomes by educating clinicians on practical, state-of-the-science strategies to optimize HBV and HCV treatment in a variety of clinical settings.

ICVH 2015 is sponsored by the International Association of Providers of AIDS Care (IAPAC), in partnership with the University of California, San Francisco (UCSF), and the International Association for the Study of the Liver (IASL). The conference Co-Chairs are Mark R. Nelson, MD (Chelsea & Westminster Hospital, London, England, UK) and Norah Terrault, MD, MPH (University of California, San Francisco, USA).

Featured topics on this year’s conference program include:

  • Viral Hepatitis: A Global Snapshot of Challenges and Opportunities
  • HBV: When Will It Be a Curable Disease?
  • Translating Clinical Trial Promise into Real-World HCV Treatment Success
  • New Tools for Assessing HBV and HCV Disease Severity, Progression, and Regression
  • Non-Alcoholic Steatosis: What Is It and How Do We Treat and Monitor?
  • HCV and Organ Transplantation
  • Treatment of HCV Cirrhotic Patients
  • Treatment of HCV for Prevention of Transmission
  • Recent Advances and Future Prospects in Therapy for Advanced HCC

Among the faculty members who will be featured at ICVH 2015 is Nancy S. Reau, MD,  University of Chicago, Chicago, IL, USA, who will deliver a Keynote Address entitled, “After the Cure: Looking Ahead in HCV Management.” In addition to Dr. Reau, other confirmed faculty members (as of June 22, 2015) include:

  • Kosh Agarwal, MD, (King’s College Hospital, London, ENGLAND)
  • Daniel Fierer, MD (Icahn School of Medicine at Mount Sinai, New York, NY, USA)
  • Ji-Dong Jia, MD, PhD (Capital University, Beijing, CHINA)
  • Seng Gee Lim, MD (National University of Singapore, SINGAPORE)
  • Mark R. Nelson, MD (Chelsea & Westminster Hospital, London, ENGLAND)
  • Mary C. Olson, DNP, ANP-BC (Cornell University, New York, NY, USA)
  • Glen Pietrandoni, RPh (Walgreens Boots Alliance, Deerfield, IL, USA)
  • Arun J. Sanyal, MD (Virginia Commonwealth University, Richmond, VA, USA)
  • Kathleen Schwarz, MD (Johns Hopkins University, Baltimore, MD, USA)
  • Vicente Soriano, MD, PhD (Hospital Carlos III, Madrid, SPAIN)
  • Diana L. Sylvestre, MD (University of California, San Francisco, CA, USA)
  • Norah Terrault, MD (University of California, San Francisco, CA, USA)
  • Tram T. Tran, MD (Cedars-Sinai Medical Center, Los Angeles, CA, USA)

Click here to view an up-to-date version of the program.


After completing this activity, participants will be able to:

  • Describe strategies for viral hepatitis diagnosis and linkages to evidence-based care and treatment
  • Define the characteristics and recommended use of approved agents for the management of viral hepatitis    
  • Identify treatment options for patients who present with viral hepatitis, including interventions to promote treatment success    
  • Discuss the management of complications due to viral hepatitis, its treatment, and/or comorbidities    
  • Explore ways to expand the categories of clinicians engaged in viral hepatitis management, including non-liver-specialists, nurses/nurse-practitioners, and pharmacists in a variety of practice settings, including primary care


Click here to Register


Aug. 7, 2015

Sept. 19, 2015

Registration Type

Early Registration

Standard Registration

IAPAC or IASL Member
(must be current)






Students* and Retired



IAPAC and IASL members enjoy discounts on conference registration fees.

Click here to join or renew your IAPAC membership.

The registration fees are listed in US dollars and apply to payments received prior to the deadlines stated above.

Registration fees include:

  • Participation in all Workshops and Satellite Symposia
  • Conference printed materials (e.g., Program and Abstracts book)

*To register as a student delegate, you must provide proof of fulltime enrolment at a recognized university or college at both the time of registration and during the conference. Please email supporting documentation within 10 days of registration to Jonathon Hess at


Payment of registration fees may be made as follows:

  • Credit card: Visa, MasterCard, American Express
  • Check/Purchase order: Payable to IAPAC, 1990 M St. NW, Suite 380, Washington DC 20036 USA
  • Bank transfer: Please email


The Hotel Nikko is the venue and official hotel for the 5th International Conference on Viral Hepatitis. The discounted room rate is $239/night plus tax, and guests may access these rates from September 17- 24, 2015 (subject to availability). Rooms may be reserved within the discounted room rate through August 20, 2015.

Hotel Nikko San Francisco  222 Mason Street– San Francisco, CA 94102

Call the hotel directly at + 1 415 394 1111 and reference the "International Conference on Viral Hepatitis" room block in order to book your hotel reservations.

For the budget-conscious traveler, the discounted room rate is unseasonably low for the San Francisco area. We encourage you to arrange your hotel accommodations as soon as possible, as hotel rooms have sold out in past conference years!



Delegates flying United Airlines receive between a 2%-10% discount on round-trip airfare to San Francisco International Airport. Discounts apply to travel 3 days before and 3 days after the conference (September 18-25, 2015). Reservations booked online via will receive an additional 3% discount without a service fee (additional 3% discount applies to published fares only and excludes travel to/from Europe, Middle East, Africa, and India). Reservation can be made online or by calling + 1 800 426 1122.


Offer Code: ZUM8152596


Additional information on ground transportation from the San Francisco International Airport can be found on their webpage, by going to

DISCLOSURE: The 5th International Conference on Viral Hepatitis is made possible through educational grants, sponsorship, and registration fees. Educational grants have been provided by AbbVie, Bristol-Myers Squibb, and Merck & Co. Additional grant applications are pending.




Conference Management Software by X-CD Technologies Inc.